This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.


We welcome your feedback, which will help improve this site.

Feedback form

REMAP-CAP: a platform trial for severely ill patients with COVID-19

The COVID-19 studies on our website have moved.

Please visit the list of nationally prioritised studies.